The company is establishing commercial production capabilities to fuel plans to launch autologous CAR T cell therapies in ...
Following through with its sizable investment commitment in China, AstraZeneca on Thursday unveiled plans to build a ...
British pharma major AstraZeneca (LSE: AZN) is stepping up its China strategy with plans to build a commercial cell therapy ...
The FDA said in a statement: “Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa. Based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results